002653 · Haisco Pharmaceutical Group Co. Ltd. Class A
56.78
CNYUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Yuan63.89B
PE
221.40
EV/EBITDA
126.6
DIV Yield
0.5%
Payout Ratio
115%
MQV Rating
1Very Strong
As at 16/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO All
- HALO Capital Efficiency
- HALO Earnings Momentum
- HALO GARP
- HALO Growth
- HALO Momentum
- HALO MQV
- Near Support
Key Fundamentals
EPS 3 yr Growth
-10.00%
EBITDA Margin
10.60%
Operating Cashflow
¥797m
Free Cash Flow Return
15.30%
ROIC
5.00%
Interest Coverage
14.00
Quick Ratio
1.60
Performance
52 weeks range
Low 42.38 - 80.83
Trade Value (12mth)
US$13,043,127.00
1 week
-5.74%
1 month
-11.25%
YTD
5.46%
1 year
1.27%
All time high
80.83
Additional Data
Shares Outstanding (Fully Diluted)
1,120m
HALO Sector
Healthcare
Next Company Report Date
21-Apr-27
Next Ex Dividend Date
04-Sep-26
Next Dividend Pay Date
04-Sep-26
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Neutral
Quality
Capital Efficiency
Very Strong
Balance Sheet
Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Jun Min Wang | Individual |
| Xiu Lian Fan | Individual |
| Ping Shen | Individual |
| Wei Zheng | Individual |
| Fei Yang | Individual |
